bay x 1005 has been researched along with Cardiovascular Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Biswal, S | 1 |
| Berti, F; Buccellati, C; Folco, G; Maclouf, J; Rossoni, G; Sala, A | 1 |
2 other study(ies) available for bay x 1005 and Cardiovascular Diseases
| Article | Year |
|---|---|
Novel cardiovascular drugs in clinical trials.
Topics: Anticholesteremic Agents; Benzaldehydes; Cardiovascular Agents; Cardiovascular Diseases; Clinical Trials as Topic; Endothelin Receptor Antagonists; Fibrinolytic Agents; Humans; Immunologic Factors; Isoxazoles; Lipoxygenase Inhibitors; Metalloendopeptidases; Oxazolidinones; Oximes; Phospholipase A2 Inhibitors; Probucol; Pyrimidines; Quinolines; Thiophenes | 2010 |
Leukotrienes in cardiovascular diseases.
Topics: Animals; Cardiovascular Diseases; Electrocardiography; Heart; In Vitro Techniques; Leukotrienes; Lipoxygenase Inhibitors; Male; Myocardium; Peroxidase; Quinolines; Rabbits; Random Allocation | 2000 |